Log in
Enquire now
‌

US Patent 8722039 Gelatin-transglutaminase hemostatic dressings and sealants

Patent 8722039 was granted and assigned to LifeBond on May, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
LifeBond
LifeBond
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8722039
Date of Patent
May 13, 2014
Patent Application Number
13341946
Date Filed
December 31, 2011
Patent Citations Received
‌
US Patent 11839695 Cross-linked protein foams and methods of using thereof a polyvalent cellular scaffold
0
Patent Primary Examiner
‌
Debbie K Ware
Patent abstract

An adhesive material for medical use comprising gelatin and a non-toxic cross-linking material such as transglutaminase. An optional embodiment of the invention includes dressings in which a layer of a transglutaminase is sandwiched between a first and second layer of gelatin. The hemostatic products are useful for the treatment of wounded tissue.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8722039 Gelatin-transglutaminase hemostatic dressings and sealants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us